HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure...

Full description

Saved in:
Bibliographic Details
Main Authors HAMANN, Lawrence G, BENDER, John A, BELEMA, Makonen, LAVOIE, Rico, RUEDIGER, Edward H, BACHAND, Carol, ROMINE, Jeffrey Lee, CHEN, Qi, LOPEZ, Omar D, KADOW, John F
Format Patent
LanguageEnglish
French
German
Published 15.02.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Bibliography:Application Number: EP20100779401